id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2017-D-1105-0002,FDA,FDA-2017-D-1105,Use of Electronic Records and Electronic Signatures in Clinical Investigations Under 21 Part 11--Questions and Answers,Other,Guidance,2017-06-21T04:00:00Z,2017,6,2017-06-21T04:00:00Z,2017-08-22T03:59:59Z,2024-10-02T13:58:50Z,,0,0,090000648271bcab
FDA-2017-D-1105-0001,FDA,FDA-2017-D-1105,"Use of Electronic Records and Electronic Signatures in Clinical
Investigations Under Part 11— Questions and Answers; Draft
Guidance for Industry; Availability",Proposed Rule,Request for Comment,2017-06-21T04:00:00Z,2017,6,2017-06-21T04:00:00Z,2017-08-22T03:59:59Z,2017-08-22T13:48:40Z,2017-12811,0,0,0900006482711aad